Christopher Verni — Vice President, Chief IP Counsel at Sarepta Therapeutics | Comparably
Sarepta Therapeutics Claimed Company
Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. read more
EMPLOYEE
PARTICIPANTS
34
TOTAL
RATINGS
432
HR or Marketing? Claim Your Free Employer Account
Christopher Verni — Vice President, Chief IP Counsel at Sarepta Therapeutics

Christopher Verni — Vice President, Chief IP Counsel at Sarepta Therapeutics

Executive Bio

Christopher Verni serves as the Vice President, Chief IP Counsel of Sarepta Therapeutics. Christopher Verni and the Sarepta Therapeutics executive team are rated a B by 24 employees.

Executive Team Culture Ratings from Sarepta Therapeutics Employees

TOP
35%
Sarepta Therapeutics' Executive Team scores in the Top 35%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Ethnicity - Caucasian 80/100
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Sarepta Therapeutics

Sarepta Therapeutics' Executive Team at a Glance

Based on 26 ratings, Sarepta Therapeutics' employees are satisfied with their Executive Team and give them a “B” or 76/100.

Sarepta Therapeutics' Executive Team ranks in the Top 30% of other companies in Boston and Top 35% of other companies on Comparably that also have 51-200 Employees.

×
Rate your company